OTTAWA Ottawa Public Health is reporting another 198 people in the city have tested positive for COVID-19, pushing the capital s pandemic total to more than 18,000 confirmed cases. Ottawa surpassed 17,000 cases on March 29. Sunday s report from Ottawa Public Health s COVID-19 dashboard shows Ottawa has seen 18,023 lab-confirmed cases of COVID-19 since the first case was confirmed on March 11, 2020. No new deaths were reported on Sunday. The city s pandemic death toll stands at 467 residents. The Ontario government did not provide a provicewide update on Sunday because of the Easter holiday. Ontario will release both Sunday and Monday s reports at 10:30 a.m. Monday. There are more people in the hospital and in the ICU, and the number of people with known active cases of COVID-19 has surpassed 1,600. The city s incidence rate of new cases per 100,000 people is nearly 115 and the estimated reproduction number remains above 1, meaning the virus is spreading.
COVID-19: Ontario on lockdown as of 12:01 a m Saturday; COVID is killing faster and younger provincial adviser warns
saultstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saultstar.com Daily Mail and Mail on Sunday newspapers.
Ottawa records highest one-day COVID-19 case count Saturday
ottawa.ctvnews.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ottawa.ctvnews.ca Daily Mail and Mail on Sunday newspapers.
COVID-19: Ontario on lockdown as of 12:01 a m Saturday; COVID is killing faster and younger provincial adviser warns
cochranetimespost.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cochranetimespost.ca Daily Mail and Mail on Sunday newspapers.
Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A
Cardiol Therapeutics Inc. (
a clinical-stage biotechnology company
focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease, today filed its audited Financial Statements and Management s Discussion and Analysis for the year ended December 31, 2020. Both are available under the Company s profile on SEDAR at www.sedar.com and on the Company s website at www.cardiolrx.com.
David Elsley, President and Chief Executive Officer of Cardiol, commented: 2020 was a very exciting year for Cardiol Therapeutics. We made extraordinary progress in our research and clinical development programs, while significantly strengthening our financial position. We are particularly excited about the progress made across our research and development programs supporting the development of CardiolRx, our pharmaceutically produced extra-strength oral f